Tuesday, 04 Nov 2025

Moderna wins EU approval for updated COVID-19 vaccine

Written by
PharmaTimes
Published
Spikevax authorised to target LP.8.1 variant ahead of 2025-2026 season Spikevax authorised to target LP.8.1 variant ahead of 2025-2026 season
Tags:
📢

Advertisement

300x250 Banner

Recent Content

COPD Biologics: Early Treatment Insights

Pulmonology • 2 hours ago

Antihypertensive Medication Guidelines

Cardiology • 4 hours ago

Juvenile Arthritis Care Transition

Rheumatology • 6 hours ago